In addition, SERPINF2 expression in leukemia cells was significantly lower in patients with B-ALL compared to AML (Supplementary Fig. 20H), but significantly higher in BCR-ABL1+ B-ALL cells versus healthy BM (Supplementary Fig. 20I). Here, SERPINF2 is linked to acute lymphoblastic leukemia.